Insulin glargine, recombinant Subcutaneous and Pramipexole Dihydrochloride
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Pramipexole Dihydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: pramipexole
Brand name: Mirapex, Mirapex ER
Synonyms: Pramipexole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Pramipexole ER Tablets
- Insulin glargine, recombinant Subcutaneous-Pramipexole Extended-Release Tablets
- Insulin glargine, recombinant Subcutaneous-Pramipexole Tablets
- Insulin glargine, recombinant Subcutaneous-Pramlintide
- Insulin glargine, recombinant Subcutaneous-Pramlintide Acetate
- Insulin glargine, recombinant Subcutaneous-Pramlintide Subcutaneous
- Pramipexole Dihydrochloride-Insulin glulisine
- Pramipexole Dihydrochloride-Insulin Glulisine (Cartridges and Pens)
- Pramipexole Dihydrochloride-Insulin Glulisine (Vials)
- Pramipexole Dihydrochloride-Insulin glulisine Subcutaneous
- Pramipexole Dihydrochloride-Insulin human inhaled Inhalation
- Pramipexole Dihydrochloride-Insulin human regular Injection